Titan Medical’s surgeon workstation
  • Titan Medical (TMD) has received the United States Patent and Trademark Office (USPTO) user experience patent
  • The patent, with No. 11,504,191, is titled “Graphical User Interface for a Robotic Surgical System”
  • The patent is directed at enhancing the surgeon user experience and generally covers a graphical user interface (GUI) overlay of a surgical workspace to track instrument movement
  • Titan Medical Inc. is a medical device company focused on enhancing robotic-assisted surgery (RAS) using innovative technology through a single access point
  • Titan Medical Inc. was unchanged at C$0.92 at 1:02 PM ET

Titan Medical (TMD) has received the United States Patent and Trademark Office (USPTO) user experience patent.

The patent, with No. 11,504,191, is titled “Graphical User Interface for a Robotic Surgical System.”

The patent is directed at enhancing the surgeon user experience and generally covers a graphical user interface (GUI) overlay of a surgical workspace to track instrument movement.

“The granting of this patent is a result of our strategic plan to independently build and protect a robust patent portfolio in robotic-assisted surgery, including around the Enos robotic single access surgical system,” noted Cary Vance, President and CEO of Titan.

“Along with recent patent application filings, including some that have recently been published, this patent demonstrates the company’s focus on being an innovation leader in single-access RAS,” he added.

The granted patent covers technology that generates a three-dimensional boundary for instruments within the surgical workspace based on movement generated by a user-controlled hand controller.

It also covers technology that provides the surgeon user with the ability to limit instrument movement based on a two-dimensional projection of the instrument’s position on the surgeon’s screen based on visual data as well as pre-operative patient imaging or scans or other patient-specific data embodying one or more keep-out zones.

Titan has developed an expansive intellectual property portfolio with over 225 pending and issued patents covering the United States and other jurisdictions.

This coverage may provide the company with multiple intellectual property options, including further protecting its RAS technologies and the potential to further license its technologies and secure strategic options.

Titan Medical Inc. is a medical device company headquartered in Toronto, Ontario, with operations in Chapel Hill, North Carolina, focused on enhancing robotic-assisted surgery (RAS) using innovative technology through a single access point.

Titan Medical Inc. was unchanged at C$0.92 at 1:02 PM ET.


More From The Market Online

InZinc reports high-grade barite results from Indy project

InZinc Mining (TSXV:IZN) reports barite results from its 2022 diamond drilling at the Indy Project in British Columbia.
PyroGenesis - PyroGenesis' STP torch for refrigerant destruction, hydrocracking and heating.

PyroGenesis to help global mining leader lower emissions

PyroGenesis Canada (TSX:PYR) signs a contract with a global mining supplier to apply its electric plasma torches towards emissions reduction.

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.